$3.90
-0.03 (-0.76%)
Open$3.97
Previous Close$3.93
Day High$4.02
Day Low$3.80
52W High$36.80
52W Low$19.49
Volume—
Avg Volume493.5K
Market Cap118.92M
P/E Ratio49.20
EPS$0.54
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+787.4% upside
Current
$3.90
$3.90
Target
$34.61
$34.61
$23.82
$34.61 avg
$34.97
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 28.35M | 25.19M | 23.71M |
| Net Income | -3,552,057 | -2,467,246 | -2,847,172 |
| Profit Margin | -12.5% | -9.8% | -12.0% |
| EBITDA | -4,683,797 | -4,050,890 | -3,804,791 |
| Free Cash Flow | -2,316,217 | -1,532,934 | -2,480,233 |
| Rev Growth | +16.8% | +20.8% | +14.1% |
| Debt/Equity | 0.40 | 0.40 | 0.41 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |